Y90: Are You Ready? is an intensive course examining radiation biology, dosimetry, radiation safety, embolotherapy and clinical office management in the use of Yttrium-90 in the treatment of liver tumors. The course will be held from 10 to 13 February 2011 in Scottsdale, Arizona, and is organised by the Society of Interventional Radiology.
Participants will be able to explore the development of hepatic artery radioembolisation devices, compare and contrast current and future device platforms, determine trends in patient selection and outcome prediction, review information on the treatment algorithm and discuss the rationale for the two-stage delivery approach and describe best practice in Y90 radiation safety and dose management.
“Interventional radiologists have been at the forefront of the research and development of Y90; there is now clear rationale for a comprehensive course on this evolving therapy. IR trainees, researchers, medical and radiation oncologists and IR technologists/nurses will gain from this most in-depth and challenging curriculum available for clinical teams interested in initiating or enhancing their practice in this area of interventional radiology,” noted Riad Salem, professor of radiology, medicine and surgery, director of interventional oncology at Northwestern University, Chicago and programme co-ordinator.
Besides Salem, programme coordinators include Matthew S. Johnson, professor of radiology and surgery and director of Interventional Oncology at Indiana University, School of Medicine and Brian F. Stainken, adjunct professor at Boston University and chair of the Diagnostic Imaging department at Roger Williams Medical Center.
For more information and registration visit: www.sirweb.org/meetings/SIR_Y90.shtml or phone (703) 691-1805. The registration ends on 12 January 2011.
